ArticleBMC veterinary research2026
Successful management of a large feline skin defect using xenogeneic bovine amniotic membrane: a case report.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAmniotic membrane has gained interest as a biological dressing due to its antimicrobial, anti-inflammatory, and pro-regenerative properties. However, its short shelf life and limited availability often constrain its clinical use in veterinary medicine. This report describes, for the first time, the use of bovine-derived AM preserved in a 1% propolis medium as a xenogeneic biological dressing for the management of extensive skin necrosis in a cat. CASE PRESENTATION: An eight-month-old female domestic cat (1.9 kg, unvaccinated) presented with severe dorsal skin sloughing and purulent discharge following subcutaneous fluid therapy for calicivirus infection. The wound involved approximately 12–15% of the body surface area. Initial management included systemic and topical antibiotics with daily cleansing for 5–7 days until the wound bed appeared dry and clean. Bovine AM preserved in propolis at −20 °C for 21 days was applied once the wound was ready for biological coverage. A second AM application was performed 30 days later using a membrane preserved for ~50 days. Quantitative analysis showed progressive wound closure from 97.1 cm² at baseline to complete epithelialization by Day 33 and full functional recovery with hair regrowth by Day 74. No recurrence, infection, or excessive scarring was observed.
conclusionThis case demonstrates that propolis-preserved bovine AM can serve as a practical, biologically active xenogeneic graft promoting rapid wound healing in cats. The findings suggest that propolis is a promising natural preservative that maintains AM bioactivity during storage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.